These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7011582)

  • 21. Inhibitory effects of para-aminobenzoic acid on the formation and mutagenicity of N-nitroso compounds.
    Gichner T; Velemínský J
    Mutagenesis; 1988 Jul; 3(4):329-31. PubMed ID: 3062321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibility of N-dimethylnitrosamine formation after parenteral administration of amidopyrine and nitrite to rats].
    Rubenchik BL; Tsapenko VF; Boĭm TM
    Eksp Onkol; 1984; 6(3):70-1. PubMed ID: 6499745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of co-cultivation of V79 cells with rat hepatocytes and rat H4IIE hepatoma cells for studying nitrosamine-induced hprt gene mutations.
    Swedmark S; Romert L; Beije B; Diaz-Pohl C; Bäckbro A; Jenssen D
    Mutagenesis; 1994 Jul; 9(4):281-7. PubMed ID: 7968567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on nitrosamine formation by the interaction between drugs and nitrite. I. Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs.
    Kawanishi T; Ohno Y; Takahashi A; Ishiwata H; Tanimura A; Kasuya Y; Omori Y
    J Toxicol Sci; 1981 Nov; 6(4):261-70. PubMed ID: 7338958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of nitrosamine formation by ascorbic acid.
    Tannenbaum SR; Wishnok JS
    Ann N Y Acad Sci; 1987; 498():354-63. PubMed ID: 3304066
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth-mediated metabolic activation of promutagens in Aspergillus nidulans.
    Bignami M; Conti G; Crebelli R; Carere A
    Mutat Res; 1981 Feb; 80(2):265-72. PubMed ID: 7010140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-nitrite interactions: species and sex differences in the formation of dimethylnitrosamine and its effects on the hepatic enzyme activities.
    Omori Y; Takahashi A; Ohno Y; Ishiwata H; Tanimura A
    Arch Toxicol Suppl; 1979; (2):349-54. PubMed ID: 288343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of soyabean and ascorbic acid on experimental carcinogenesis.
    Fitzsimons JT; Orson NV; el-Aaser AA
    Comp Biochem Physiol A Comp Physiol; 1989; 93(1):285-90. PubMed ID: 2568231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-mediated mutagenicity of tobacco snuff: its possible mechanism.
    Whong WZ; Stewart JD; Wang YK; Ong T
    Mutat Res; 1987 Apr; 177(2):241-6. PubMed ID: 3550442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nitrosamine formation by ascorbic acid.
    Tannenbaum SR; Wishnok JS; Leaf CD
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):247S-250S. PubMed ID: 1985394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief communication: ascorbic acid blocking of aminopyrine nitrosation in NZO-B1 mice.
    Greenblatt M
    J Natl Cancer Inst; 1973 Apr; 50(4):1055-6. PubMed ID: 4703770
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo stability of nitrite and nitrosamine formation in the dog stomach: effect of nitrite and amine concentration and of ascorbic acid.
    Lintas CL; Clark A; Fox J; Tannenbaum SR; Newberne PM
    Carcinogenesis; 1982; 3(2):161-5. PubMed ID: 7067044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mutagenic activity of ascorbic acid in vitro and in vivo.
    Norkus EP; Kuenzig W; Conney AH
    Mutat Res; 1983 Apr; 117(1-2):183-91. PubMed ID: 6403856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro effect of ascorbate on the spontaneous reduction of sodium nitrite concentration in a reaction mixture.
    Basu TK; Weiser T; Dempster JF
    Int J Vitam Nutr Res; 1984; 54(2-3):233-6. PubMed ID: 6500848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ascorbate on amine-nitrite carcinogenicity.
    Fong YY; Chan WC
    IARC Sci Publ (1971); 1976; (14):461-4. PubMed ID: 1002210
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerating effect of ascorbic acid on N-nitrosamine formation and nitrosation by oxyhyponitrite.
    Chang SK; Harrington GW; Rothstein M; Shergalis WA; Swern D; Vohra SK
    Cancer Res; 1979 Oct; 39(10):3871-4. PubMed ID: 38902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of oxytetracycline.
    Blitek D; Pieńkowska K; Gajcy H; Koziorowska J
    Mutat Res; 1983 Apr; 117(1-2):193-9. PubMed ID: 6339906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of primary amines combined with nitrite.
    Hussain S; Ehrenberg L
    Mutat Res; 1974 Oct; 26(5):419-22. PubMed ID: 4606828
    [No Abstract]   [Full Text] [Related]  

  • 40. Formation of volatile nitrosamines by drug-nitrite interactions under physiological conditions.
    Sakai A; Inoue T; Tanimura A
    Gan; 1984 Mar; 75(3):245-52. PubMed ID: 6724228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.